Diagnostics; making a difference

Member Press Releases

Current Articles | Categories | Search | Syndication

02 December 2016  Joanne Hunter
QuantuMDx receives grant funding from Gates Foundation for diagnostic to reach the missing 4.3 million TB cases a year
By Joanne Hunter @ 09:30 :: 2 Views

28th November 2016, Newcastle upon Tyne, UK. QuantuMDx announced today that it received funding from the Bill & Melinda Gates Foundation to further develop and test its CAPTURE-XT™ pathogen concentration technology and Q-POC™ molecular diagnostic (MDx) platform for rapid low cost TB detection and drug susceptibility testing (DST) in response to World Health Organisation target product profiles. The technology is being developed for introduction into peripheral microscopy centres, clinics and hospitals in high burden countries, finally providing a low cost MDx solution to reach the 4.3 million people with TB who are ‘missed’ by healthcare systems each year.

Read More

02 December 2016  Joanne Hunter
Cytox presentations on studies with breakthrough genetic biomarker research assay for Alzheimer’s disease risk assessment at CTAD 2016
By Joanne Hunter @ 09:12 :: 3 Views

1st December 2016
, Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, has announced that it will be presenting two posters at the Clinical Trials on Alzheimer’s Disease Conference, CTAD 2016, San Diego, USA, December 8-10th, discussing SNP (single nucleotide polymorphism) profiling and the use of polygenic risk score algorithms for stratification of early subjects for risk of Alzheimer's disease (AD).

Read More

29 November 2016  Joanne Hunter
Beckman Coulter announces significant investment in UK microbiology market with DxN VERIS Molecular Diagnostics and MicroScan Microbiology Systems
By Joanne Hunter @ 11:01 :: 2 Views

High Wycombe, UK, 29 November 2016: Beckman Coulter has launched two automated systems in the UK to ease rapidly increasing workloads in microbiology and virology departments. The DxN VERIS Molecular Diagnostics system, for same-day molecular viral load testing, and the MicroScan Microbiology Systems for microorganism identification (ID) and antimicrobial susceptibility testing (AST), both rapidly and accurately identify therapeutic pathways for patient management. This high-throughput testing significantly streamlines laboratory workflows, and reduces time to patient therapy diagnoses. The launch marks the advent of a significant investment in the UK microbiology market by Beckman Coulter with further product introductions scheduled.

Read More

22 November 2016  Joanne Hunter
OGT announces commercial and financial highlights for FY 2016
By Joanne Hunter @ 14:19 :: 36 Views

Oxford, UK – 22 November 2016. Oxford Gene Technology (OGT), The Molecular Genetics Company has announced continued strong sales of its highly integrated molecular genetics product portfolio, delivering sustainable, profitable growth. Commercial and financial highlights for the year ended 30 September show the company delivering product sales of £18.4m, up 29% on FY 2015.

  • Total revenue grew by 15% to £19.7m (FY2015: £17.1m)
  • Product revenues grew 29% to £18.4m (FY2015: £14.3m)
  • Fully integrated portfolio delivers sustainable profitable growth
Read More

07 November 2016  Joanne Hunter
By Joanne Hunter @ 12:25 :: 73 Views

ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB® Assay, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the assay is intended to detect 150 variants belonging to the 5 main families of Carbapenem-Resistant genes: KPC, NDM, VIM, IMP, and OXA-48 like and differentiate the main classes.

Read More

07 November 2016  Joanne Hunter
Compliant Air Transport for Biological Samples
By Joanne Hunter @ 10:21 :: 69 Views

IATA standard 95kPa Flexible Secondary Pouches for the safe air transport of biological samples are now available from Alpha Laboratories. These form part of the wide range of convenient and cost effective sample packaging materials that help ensure your UN3373 compliance. 

Read More

03 November 2016  Joanne Hunter
Up to 10-fold increase in assay sensitivity - discover Morffi™ at MEDICA 2016
By Joanne Hunter @ 15:54 :: 74 Views

BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016. This year’s exhibition, which takes place in Dusseldorf from the 14th to the 17th of November, will give delegates a chance to explore this innovative technology and learn about the complete range of high quality raw materials and services the company offers to the IVD industry.

Read More

03 November 2016  Joanne Hunter
EKF showcases new connectivity solution for point-of-care HbA1c analyzers at Medica 2016
By Joanne Hunter @ 14:18 :: 70 Views

Cardiff, UK – 3rd November 2016 – EKF Diagnostics, the global in vitro diagnostics company, announces that it will be previewing a new point-of-care (POC) connectivity solution for its range of HbA1c analyzers at Medica 2016 in Düsseldorf from 14–17th November. In Hall 3 / C70, EKF will be showcasing the new connectivity package for Quo-Test™ and Quo-Lab™ HbA1c analyzers, enabling secure bi-directional communication between these POC analyzers and a multitude of central data management systems. Using the industry recognized POCT1-A2 communication protocol, EKF’s connectivity solution unlocks a host of new features aimed at improving security and quality control (QC) for diabetic HbA1c testing. 

Read More

01 November 2016  Joanne Hunter
30 Minute or Less Molecular Flu/RSV Test Now Available - Why Choose Between Fast or Accurate When You Can Have Both?
By Joanne Hunter @ 13:34 :: 82 Views


With the flu season fast approaching, healthcare providers no longer need to choose between a fast test result or an accurate test result for patients suspected of influenza infection. Now, they can have both, with Xpert® Xpress Flu/RSV from Cepheid, a new test that delivers reference-quality molecular test results in as little as twenty minutes.1

Read More

31 October 2016  Joanne Hunter
Placing and Subscription to raise £3.3 million - Notice of General Meeting
By Joanne Hunter @ 09:35 :: 85 Views

31 October 2016:  Proteome Sciences plc (AIM:PRM) is pleased to announce it has raised approximately £3.3 million, before expenses, through an oversubscribed placing for cash (“Placing”) of 65,858,100 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares" and the "Placing Shares") and a subscription (the "Subscription") of 400,000 new Ordinary Shares (the “Subscription Shares”) both at a price of 5 pence per new Ordinary Share (the Placing and Subscription together, the "Fundraise"). £2.3m has been raised utilising existing shareholder authority to allot new Ordinary Shares, the balance of £1.0m will be subject to shareholder approval at a General Meeting to be held on 29 November 2016.

Read More

Previous Page | Next Page